1. Home
  2. ASMB vs PHUN Comparison

ASMB vs PHUN Comparison

Compare ASMB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • PHUN
  • Stock Information
  • Founded
  • ASMB 2005
  • PHUN 2009
  • Country
  • ASMB United States
  • PHUN United States
  • Employees
  • ASMB N/A
  • PHUN N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • ASMB Health Care
  • PHUN Technology
  • Exchange
  • ASMB Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • ASMB 84.5M
  • PHUN 88.8M
  • IPO Year
  • ASMB 2010
  • PHUN N/A
  • Fundamental
  • Price
  • ASMB $13.30
  • PHUN $3.88
  • Analyst Decision
  • ASMB Buy
  • PHUN Strong Buy
  • Analyst Count
  • ASMB 2
  • PHUN 3
  • Target Price
  • ASMB $35.00
  • PHUN $13.00
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • PHUN 1.4M
  • Earning Date
  • ASMB 03-27-2025
  • PHUN 03-11-2025
  • Dividend Yield
  • ASMB N/A
  • PHUN N/A
  • EPS Growth
  • ASMB N/A
  • PHUN N/A
  • EPS
  • ASMB N/A
  • PHUN N/A
  • Revenue
  • ASMB $28,326,000.00
  • PHUN $3,537,000.00
  • Revenue This Year
  • ASMB $282.16
  • PHUN N/A
  • Revenue Next Year
  • ASMB N/A
  • PHUN $93.33
  • P/E Ratio
  • ASMB N/A
  • PHUN N/A
  • Revenue Growth
  • ASMB N/A
  • PHUN N/A
  • 52 Week Low
  • ASMB $11.01
  • PHUN $2.85
  • 52 Week High
  • ASMB $19.93
  • PHUN $17.99
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • PHUN 38.74
  • Support Level
  • ASMB $13.13
  • PHUN $3.71
  • Resistance Level
  • ASMB $14.25
  • PHUN $4.04
  • Average True Range (ATR)
  • ASMB 0.55
  • PHUN 0.27
  • MACD
  • ASMB -0.07
  • PHUN -0.06
  • Stochastic Oscillator
  • ASMB 15.38
  • PHUN 14.28

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.

Share on Social Networks: